Funder
Natural Science Foundation of China
Fundamental Research Funds for the Provincial Universities of Zhejiang
Subject
Applied Microbiology and Biotechnology,Biochemistry,Biotechnology,Bioengineering
Reference40 articles.
1. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes;Aschner;Diabetes Care,2006
2. Sitagliptin manufacture: a compelling tale of green chemistry, process intensification, and industrial asymmetric catalysis;Desai;Angew. Chem. Int. Ed. Engl.,2015
3. Dipeptidyl peptidase‐4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin;Herman;Clin. Pharmacol. Ther.,2007
4. (2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl]-1-(2,4,5-trifluorophenyl) butan-2-amine : a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes;Kim;J. Med. Chem.,2005
5. ω-Transaminase for asymmetric synthesis of chiral amines and unnatural amino acids;Cheng;Chin. J. Bioprocess. Eng.,2018
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献